Animal Drug Compounding Market Key Players Analysis - Wedgewood Pharmacy; Vimian; Pharmaca; Akina Animal Health; Triangle Compounding.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Animal Drug Compounding Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Livestock Animals), By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, GI Drugs), By Route of Administration (Oral, Injectable, Topical), By Dosage Form (Suspensions, Solutions, and Capsules)- Market Outlook And Industry Analysis 2034"

The global Animal Drug Compounding market is estimated to reach over 5.15 billion by the year 2034, exhibiting a CAGR of 8.2% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1664

The advantages of compounded medications, including improved patient compliance and cost-effectiveness, have led to their increased recommendation by veterinarians. According to research by the American Veterinary Medical Association (AVMA), the FDA's heightened awareness of drug shortages and the significant markup of medications on the secondary market have contributed to a marked rise in the compounding of veterinary drugs over the past five years. Additionally, compounded formulations are utilized when commercially available medications are ineffective or when the required dosage form is unavailable for certain animals. For example, a customized formulation may be necessary for animals such as parakeets or cats that refuse conventional pill forms.

Moreover, the number of countries reporting pet ownership has grown significantly, alongside a global surge in pet adoption. While activity levels were subdued in the first half of the year, there was a notable rebound following the easing of pandemic-related restrictions in the latter half. The ongoing global drug shortages post-pandemic, combined with an increasing incidence of drug failures, are expected to drive further demand for compounding pharmacy services.

List of Prominent Players in the Animal Drug Compounding Market:
• Akina Animal Health
• Aurora Compounding
• Caringbah Compounding Pharmacy
• Central Compounding Center South
• Chiron Compounding Pharmacy
• Custom Med Compounding Pharmacy
• Davis Islands Pharmacy and Compounding Lab
• Dougherty's Pharmacy
• Hoye's Pharmacy
• Medisca Inc.
• MEDS Canadian Compounding Pharmacy
• Millers Pharmacy
• Pace Pharmacy
• People's Choice Pharmacy
• Pharmaca.
• Pratt's Compounding Pharmacy
• Sixth Avenue Medical Pharmacy
• Smith Caldwell Drug Store
• Smith's Pharmacy
• Specialist Compounding Pharmacy Pte Ltd.
• Tache Pharmacy
• Triangle Compounding Pharmacy Inc.
• Vertisis Custom Pharmacy
• Victoria Compounding Pharmacy
• Vimian
• Wedgewood Pharmacy
• Wellness Pharmacy of Cary

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers:
Central nervous system (CNS) inflammation is a primary cause of neurological disorders in cats and dogs. Common symptoms in affected animals include seizures, impaired limb coordination, vision loss, and behavioral abnormalities. According to the International Journal of Pharmaceutical Compounding, CNS medications account for approximately 40% of all veterinary pharmaceutical solutions. Veterinary compounding specialists enhance patient compliance by masking unpleasant drug flavors and improving the palatability and texture of formulations. The market outlook for compounding pharmacies is positively correlated with their ability to develop effective, customized dosages that meet the specific needs of animal patients.

Challenges:
Despite the benefits of compounded veterinary medications, the potential for drug antagonism poses a significant risk to their efficacy. Moreover, compounded drugs are not subject to FDA approval or guarantee of safety, creating regulatory gaps that may impact animal welfare standards. While manufacturers of compounded veterinary drugs are adopting strategies to address these challenges, the lack of formal regulation continues to present barriers to sustained market growth.

Regional Trends:
North America holds the largest revenue share in the veterinary compounding market, driven by increasing pet ownership, strategic initiatives by leading manufacturers, and a steady flow of new product launches. For example, Chewy, Inc., a prominent player in the pet e-commerce sector, expanded its pharmacy division in November 2020 to include compounded veterinary pharmaceuticals tailored to meet the specific health requirements of dogs, further bolstering regional market growth.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1664

Recent Developments:
• In Feb 2023, Wedgewood Pharmacy recently acquired the full-service testing facility Front Range Laboratories (FRL) in Loveland, Colorado. FRL performs analytical and microbiological testing, product stability testing, and other services to serve the testing needs of pharmacies nationwide. Wedgewood Pharmacy intends to preserve the FRL brand, which is revered across the compounding pharmacy industry as a source of superior services.
• In September 2022, On the use of bulk drug substances for compounding animal treatments, the Food and Drug Administration released final advice, which was unveiled in April. The FDA outlines the conditions under which it will exercise enforcement discretion in relation to violations of the Federal Food, Drug, and Cosmetic Act for drug approval, labelling, and manufacturing when pharmacists and veterinarians compound drugs from drug (bulk) substances for animal patients in Guidance for Industry #256, Compounding Animal Drugs from Bulk Drug Substances.

Segmentation of Animal Drug Compounding Market-
By Animal Type-
• Companion Animals
o Dogs
o Cats
o Others
• Livestock Animals
By Product-
• Anti-infectives
o Metranidazole
o Ketaconazole
o Others
• Anti-inflammatory
o Prednisolone
o Others
• CNS Agents
o Potassium Bromide
o Gabapentin
o Other CNS Agents
• GI Drugs
o Apomorphine
o Ursodiol
o Cisapride
o Other GI Drugs
• Others
o Methimazole
o Others
By Route of Administration-
• Oral
• Injectable
• Topical
• Others
By Dosage Form-
• Suspensions
• Solutions
• Capsules
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa

Read Overview Report- https://www.insightaceanalytic.com/report/animal-drug-compounding-market/1664

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.